4.7 Article

Neuroinflammation increases GABAergic tone and impairs cognitive and motor function in hyperammonemia by increasing GAT-3 membrane expression. Reversal by sulforaphane by promoting M2 polarization of microglia

Related references

Note: Only part of the references are listed.
Review Neurosciences

Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases

Yu Tang et al.

MOLECULAR NEUROBIOLOGY (2016)

Article Medicine, General & Internal

Hyperinsulinism Hyperammonemia Syndrome, a Rare Clinical Constellation

Jonathan Hussain et al.

JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS (2016)

Article Biochemistry & Molecular Biology

Cleaning up after ICH: the role of Nrf2 in modulating microglia function and hematoma clearance

Xiurong Zhao et al.

JOURNAL OF NEUROCHEMISTRY (2015)

Article Neurosciences

Morphological changes of cortical pyramidal neurons in hepatic encephalopathy

Jeng-Rung Chen et al.

BMC NEUROSCIENCE (2014)

Article Gastroenterology & Hepatology

Characterisation of temporal microglia and astrocyte immune responses in bile duct-ligated rat models of cirrhosis

Gavin A. K. Wright et al.

LIVER INTERNATIONAL (2014)

Review Neurosciences

Hepatic encephalopathy: effects of liver failure on brain function

Vicente Felipo

NATURE REVIEWS NEUROSCIENCE (2013)

Article Endocrinology & Metabolism

Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy

Vicente Felipo et al.

METABOLIC BRAIN DISEASE (2012)

Article Gastroenterology & Hepatology

Microglia Activation in Hepatic Encephalopathy in Rats and Humans

Irina Zemtsova et al.

HEPATOLOGY (2011)

Review Rheumatology

Kinase inhibitors: a new approach to rheumatoid arthritis treatment

Stanley Cohen et al.

CURRENT OPINION IN RHEUMATOLOGY (2010)

Article Gastroenterology & Hepatology

Hyperammonemia Increases GABAergic Tone in the Cerebellum but Decreases It in the Rat Cortex

Omar Cauli et al.

GASTROENTEROLOGY (2009)

Article Gastroenterology & Hepatology

IL-6 and IL-18 in Blood May Discriminate Cirrhotic Patients With and Without Minimal Hepatic Encephalopathy

Carmina Montoliu et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2009)

Article Gastroenterology & Hepatology

Experimental models of hepatic encephalopathy: ISHEN guidelines

Roger F. Butterworth et al.

LIVER INTERNATIONAL (2009)

Article Endocrinology & Metabolism

Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy

Omar Cauli et al.

METABOLIC BRAIN DISEASE (2009)

Article Immunology

The transcription factor Nrf2 is a therapeutic target against brain inflammation

Nadia G. Innamorato et al.

JOURNAL OF IMMUNOLOGY (2008)

Article Gastroenterology & Hepatology

Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy

Carroll B. Leevy et al.

DIGESTIVE DISEASES AND SCIENCES (2007)

Article Endocrinology & Metabolism

Attention, memory, and cognitive function in hepatic encephalopathy

K Weissenborn et al.

METABOLIC BRAIN DISEASE (2005)

Article Gastroenterology & Hepatology

Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis

DL Shawcross et al.

JOURNAL OF HEPATOLOGY (2004)

Review Neurosciences

Neurobiology of ammonia

V Felipo et al.

PROGRESS IN NEUROBIOLOGY (2002)